Harp Diagnostics
Remote & rapid monitoring platform for superior disease management of IBD and other GI conditions
Company Overview
Snapshot
Founded in December 2022, Harp Diagnostics operates with 1-10 employees. The company has secured funding across four rounds, with The Trendlines Group participating as a lead investor. In April 2025, Harp Diagnostics won the IBD Innovate Conference Shark Tank competition, recognizing its innovative remote rapid monitoring platform for inflammatory bowel disease.
Business overview
Harp Diagnostics is developing an automated, user-friendly, and rapid stool testing platform for home monitoring of gastrointestinal conditions, specifically Inflammatory Bowel Diseases (IBD) such as Crohn’s and Colitis. The platform provides an end-to-end solution, including seamless sample collection and rapid, accurate results with built-in safeguards to minimize human error. Its patented portable device can be used by patients at home or by healthcare providers at the point-of-care, with test data shared via a cloud-connected system to facilitate real-time, data-driven treatment decisions. The company serves the healthcare and life sciences sectors, targeting both patients and providers with its medical monitoring technology.
Strategic signal
Harp Diagnostics is currently engaged in a fundraising round via ExitValley to support clinical trials for its diagnostic tool. This initiative is critical for advancing their goal of becoming the first company to receive FDA approval for a home-use diagnostic tool in this field, following positive preliminary feedback from the FDA. This strategic move signals the company's commitment to regulatory validation and market entry, positioning it for significant growth in the remote patient monitoring and diagnostic market.
Log in to access full profile ›Company Intelligence Q&A
- What is Harp Diagnostics' core product?
- Harp Diagnostics is developing HARP 360, the world’s first automated, user-friendly, and rapid stool testing platform for home monitoring of gastrointestinal conditions like Inflammatory Bowel Diseases (IBD).
- When was Harp Diagnostics founded?
- Harp Diagnostics was founded in December 2022.
- What was a significant recent achievement for Harp Diagnostics?
- In April 2025, Harp Diagnostics won the IBD Innovate Conference Shark Tank competition, recognized for its innovative remote rapid monitoring platform for managing inflammatory bowel disease.
- Which investor participated in Harp Diagnostics' funding round?
- In February 2023, The Trendlines Group participated as a lead investor in a funding round for.
- What is Harp Diagnostics' current product development stage?
- Harp Diagnostics' product is currently in the R&D stage, with ongoing efforts to conduct clinical trials for its diagnostic tool.